Log in to your Inderes Free account to see all free content on this page.
Double Bond Pharmaceutical International
0.11 SEK
+0.47 %
Less than 1K followers
DBP B
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Double Bond Pharmaceutical International
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.2 | 0.2 | 1.1 | 0.1 | 0.0 | 0.1 | ||
| EBITDA | -1.7 | -1.9 | -7.6 | -0.4 | -0.3 | -0.4 | -0.4 | -1.5 |
| EBIT | -1.7 | -1.9 | -7.8 | -0.4 | -0.4 | -0.5 | -0.5 | -1.7 |
| EBIT-% | -747.8 % | -872.7 % | -711.9 % | -770.5 % | -2,005.6 % | -2,006.4 % | ||
| Profit before taxes | -0.9 | -5.0 | -13.2 | -1.1 | -0.4 | -0.5 | 1.7 | -0.3 |
| Net income | -0.9 | -5.0 | -13.2 | -1.1 | -0.4 | -0.5 | 1.7 | -0.3 |
Login required
This content is only available for logged in users